Skip to main content
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.880
-0.110 (-2.20%)
Mar 9, 2026, 2:44 PM EDT - Market open

Radiopharm Theranostics Revenue

Radiopharm Theranostics had revenue of 6.20M AUD in the half year ending December 31, 2025, with 52.60% growth. This brings the company's revenue in the last twelve months to 16.28M, up 4,823.49% year-over-year. In the fiscal year ending June 30, 2025, Radiopharm Theranostics had annual revenue of 12.51M with 538.86% growth.

Revenue (ttm)
16.28M AUD
Revenue Growth
+4,823.49%
P/S Ratio
4.81
Revenue / Employee
1,162,745 AUD
Employees
14
Market Cap
52.22M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202512.51M10.55M538.86%
Jun 30, 20241.96M-4.25M-68.46%
Jun 30, 20236.21M--
Jun 30, 2022---
Jun 30, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Metagenomi Therapeutics 25.21M
MindWalk Holdings 19.02M
Plus Therapeutics 5.26M
Alterity Therapeutics 4.43M
Nutriband 2.28M
Revenue Rankings

RADX News

More News